These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27893662)

  • 1. The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion.
    Allen JC; Nault JC; Zhu G; Khor AYK; Liu J; Lim TKH; Zucman-Rossi J; Chow PKH
    Medicine (Baltimore); 2016 Nov; 95(47):e5263. PubMed ID: 27893662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
    Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
    BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of transcriptomic molecular classification, biological behavior, and clinicopathological features in hepatocellular carcinoma.
    Chen R; Zhou Z; Chen Y; Huang A; Chen L
    Expert Rev Mol Diagn; 2023 Jan; 23(1):71-84. PubMed ID: 36655856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
    Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Sakamoto K; Hamada K; Ishitsuka H; Miyamoto T; Uchimura S; Hamamoto Y
    FEBS Lett; 2005 Feb; 579(5):1089-100. PubMed ID: 15710396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
    Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
    J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-expression signature of vascular invasion in hepatocellular carcinoma.
    Mínguez B; Hoshida Y; Villanueva A; Toffanin S; Cabellos L; Thung S; Mandeli J; Sia D; April C; Fan JB; Lachenmayer A; Savic R; Roayaie S; Mazzaferro V; Bruix J; Schwartz M; Friedman SL; Llovet JM
    J Hepatol; 2011 Dec; 55(6):1325-31. PubMed ID: 21703203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.
    Beyoğlu D; Imbeaud S; Maurhofer O; Bioulac-Sage P; Zucman-Rossi J; Dufour JF; Idle JR
    Hepatology; 2013 Jul; 58(1):229-38. PubMed ID: 23463346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection.
    Nault JC; De Reyniès A; Villanueva A; Calderaro J; Rebouissou S; Couchy G; Decaens T; Franco D; Imbeaud S; Rousseau F; Azoulay D; Saric J; Blanc JF; Balabaud C; Bioulac-Sage P; Laurent A; Laurent-Puig P; Llovet JM; Zucman-Rossi J
    Gastroenterology; 2013 Jul; 145(1):176-187. PubMed ID: 23567350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
    Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
    Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
    Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
    J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma.
    Bai DS; Dai Z; Zhou J; Liu YK; Qiu SJ; Tan CJ; Shi YH; Huang C; Wang Z; He YF; Fan J
    Hepatology; 2009 Feb; 49(2):460-70. PubMed ID: 19053044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma.
    Park ER; Kim SB; Lee JS; Kim YH; Lee DH; Cho EH; Park SH; Han CJ; Kim BY; Choi DW; Yoo YD; Yu A; Lee JW; Jang JJ; Park YN; Suh KS; Lee KH
    Cancer Med; 2017 Apr; 6(4):749-760. PubMed ID: 28332314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.